カテゴリー： Allied Market Research, 世界, 医療/バイオ

子宮摘出機器の世界市場2021-2031：機会分析・産業予測

◆英語タイトル：Hysterectomy Device Market By Disease type (Uterine Cancer, Fibroids, Chronic pelvic pain, Others), By Surgical approach (Vaginal hysterectomy, Laparoscopic hysterectomy, Robotic assisted laparoscopic hysterectomy, Abdominal hysterectomy), By End User (Hospitals, Ambulatory Surgical Centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Allied Market Researchが発行した調査報告書（ALD23MY024）◆商品コード：ALD23MY024
◆発行会社（リサーチ会社）：Allied Market Research
◆発行日：2023年2月
◆ページ数：389
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Online Only（1名閲覧、印刷不可）USD3,570 ⇒換算￥542,640見積依頼/購入/質問フォーム
Single User（1名閲覧）USD5,730 ⇒換算￥870,960見積依頼/購入/質問フォーム
Enterprise User（閲覧人数無制限）USD9,600 ⇒換算￥1,459,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

アライドマーケットリサーチ社の市場調査書では、世界の子宮摘出機器市場規模が2021年には328.09百万ドルから2031年には566.5百万ドルに達し、2022年から2031年の間にCAGR 5.63％増加すると見込まれています。こちらの調査書は、子宮摘出機器の世界市場を広く調査・分析し、イントロダクション、エグゼクティブサマリー、市場概要、疾患別（子宮がん、子宮筋腫、慢性骨盤痛、その他）分析、外科的アプローチ別（膣式子宮摘出術、腹腔鏡下子宮全摘術、ロボット補助腹腔鏡下子宮全摘術、腹式子宮摘出術）分析、エンドユーザー別（病院、外来手術センター、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米/中東・アフリカ）分析、競争状況、企業情報などを掲載しています。なお、本書には、Medtronic plc、Laborie, Inc、fortimedix surgical b.v.、B. Braun Melsungen AG、Conkin surgical instruments ltd、Richard Wolf GmbH、CONMED Corporation、Johnson & Johnson、Cooper Companies, Inc.、KARL STORZ GmbH & Co. KGなどの企業情報が含まれています。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・世界の子宮摘出機器市場規模：疾患別
- 子宮がんにおける市場規模
- 子宮筋腫における市場規模
- 慢性骨盤痛における市場規模
- その他疾患における市場規模
・世界の子宮摘出機器市場規模：外科的アプローチ別
- 膣式子宮摘出術における市場規模
- 腹腔鏡下子宮全摘術における市場規模
- ロボット補助腹腔鏡下子宮全摘術における市場規模
- 腹式子宮摘出術における市場規模
・世界の子宮摘出機器市場規模：エンドユーザー別
- 病院における市場規模
- 外来手術センターにおける市場規模
- その他エンドユーザーにおける市場規模
・世界の子宮摘出機器市場規模：地域別
- 北米の子宮摘出機器市場規模
- ヨーロッパの子宮摘出機器市場規模
- アジア太平洋の子宮摘出機器市場規模
- 中南米/中東・アフリカの子宮摘出機器市場規模
・競争状況
・企業情報

世界の子宮摘出機器市場は、2021年に3億2,809万ドルと評価され、2022年から2031年まで年平均成長率5.63%で成長して2031年には5億6,650万ドルに達すると予測されています。 
子宮と、頻度は低いですが子宮頸部の外科的除去は、子宮摘出術として知られています。子宮摘出術は、手術の理由によっては、卵巣や卵管など近隣の臓器や組織の摘出を伴うこともあります。子宮筋腫、子宮内膜症、子宮異常出血など、さまざまな婦人科疾患の治療として行われるのが一般的です。子宮摘出術は、開腹手術、腹腔鏡手術、ロボット支援手術など、さまざまな手術手技を用いて行われます。 
子宮摘出機器市場の推進要因は、子宮体癌の有病率の上昇です。子宮体がんは最も一般的な婦人科がんの1つであり、子宮摘出術はこの疾患に対する一般的な治療法です。さらに、さまざまな政府組織やNGOが女性の健康について人々の意識を高めていることも、市場の成長を後押ししています。さらに、子宮摘出器具は近年多くの技術的進歩を遂げており、手術結果の改善、患者の不快感の軽減、回復時間の短縮も市場成長を後押ししています。 
しかし、婦人科疾患の治療のための代替治療の利用可能性などの要因は、子宮摘出機器市場の成長を妨げると予想されます。一方、低侵襲または低侵襲手術に対する需要の急増は、市場に成長機会を提供すると予測されています。 

世界の子宮摘出機器市場は、疾患タイプ、外科的アプローチ、エンドユーザー、地域に区分されます。
疾患タイプ別では、子宮癌、子宮筋腫、慢性骨盤痛、その他に分類されます。
外科的アプローチ別では、市場は膣式子宮摘出術、腹腔鏡下子宮摘出術、ロボット支援腹腔鏡下子宮摘出術、腹式子宮摘出術に分類されます。
エンドユーザー別では、市場は病院、外来手術センター、その他に分類されます。
地域別では、北米（米国、カナダ、メキシコ）、欧州（ドイツ、フランス、英国、イタリア、スペイン、その他欧州）、アジア太平洋（日本、中国、オーストラリア、インド、韓国、その他アジア太平洋）、LAMEA（ブラジル、南アフリカ、サウジアラビア、その他LAMEA）に市場を分けて分析しています。 

世界の子宮摘出機器市場で事業を展開する主な主要企業は、Conkin surgical instruments ltd、Cooper Surgical、B. braun medical ltd、KARL STORZ GmbH & Co. KG、Conmed Corporation、Jhonson & Jhonson、Richard Wolf GmbH、Fortimedix Surgical、Medtronic corporation、Laborie, Inc. などです。

〈ステークホルダーにとっての主なメリット〉
・当レポートは、2021年から2031年までの子宮摘出機器市場分析の市場セグメント、現在の動向、予測、ダイナミクスを定量的に分析し、子宮摘出機器市場の有力な機会を特定します。
・主要な促進要因、阻害要因、機会に関する情報とともに市場調査を提供します。
・ポーターのファイブフォース分析により、バイヤーとサプライヤーの潜在力を明らかにし、ステークホルダーが利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるようにします。
・子宮摘出機器市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。
・各地域の主要国を世界市場への収益貢献度に応じてマッピングしています。
・市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
地域別および世界の子宮摘出機器市場動向、主要企業、市場セグ・メント、応用分野、市場成長戦略の分析を含みます。

〈主要市場セグメント〉
疾患タイプ別
子宮癌
子宮筋腫
慢性骨盤痛
その他

エンドユーザー別
病院
外来手術センター
その他

外科的アプローチ別
ロボット支援腹腔鏡下子宮全摘術
腹式子宮全摘術
腟式子宮全摘術
腹腔鏡下子宮全摘術

地域別
・北米
アメリカ
カナダ
メキシコ
・ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
その他のヨーロッパ
・アジア太平洋
日本
中国
インド
オーストラリア
韓国
その他のアジア太平洋地域
・LAMEA
ブラジル
サウジアラビア
南アフリカ
その他のLAMEA地域

〈主要市場プレイヤー〉
Medtronic plc
Laborie, Inc
fortimedix surgical b.v.
B. Braun Melsungen AG
Conkin surgical instruments ltd
Richard Wolf GmbH
CONMED Corporation
Johnson & Johnson
Cooper Companies, Inc.
KARL STORZ GmbH & Co. KG

❖ レポートの目次 ❖

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in prevalence of uterine cancer
3.4.1.2. Increase in awareness of women’s health
3.4.1.3. Technological advancements in hysterectomy devices

3.4.2. Restraints
3.4.2.1. Availability of alternative treatments

3.4.3. Opportunities
3.4.3.1. Increase in demand for the minimally invasive procedures

3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Uterine Cancer
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Fibroids
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Chronic pelvic pain
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. Others
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
CHAPTER 5: HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH
5.1. Overview
5.1.1. Market size and forecast
5.2. Vaginal hysterectomy
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Laparoscopic hysterectomy
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Robotic assisted laparoscopic hysterectomy
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Abdominal hysterectomy
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
CHAPTER 6: HYSTERECTOMY DEVICE MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Ambulatory Surgical Centers
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: HYSTERECTOMY DEVICE MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Disease type
7.2.3. Market size and forecast, by Surgical approach
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Disease type
7.2.5.1.3. Market size and forecast, by Surgical approach
7.2.5.1.4. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Disease type
7.2.5.2.3. Market size and forecast, by Surgical approach
7.2.5.2.4. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Disease type
7.2.5.3.3. Market size and forecast, by Surgical approach
7.2.5.3.4. Market size and forecast, by End User
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Disease type
7.3.3. Market size and forecast, by Surgical approach
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Disease type
7.3.5.1.3. Market size and forecast, by Surgical approach
7.3.5.1.4. Market size and forecast, by End User
7.3.5.2. France
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Disease type
7.3.5.2.3. Market size and forecast, by Surgical approach
7.3.5.2.4. Market size and forecast, by End User
7.3.5.3. UK
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Disease type
7.3.5.3.3. Market size and forecast, by Surgical approach
7.3.5.3.4. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Disease type
7.3.5.4.3. Market size and forecast, by Surgical approach
7.3.5.4.4. Market size and forecast, by End User
7.3.5.5. Spain
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Disease type
7.3.5.5.3. Market size and forecast, by Surgical approach
7.3.5.5.4. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Disease type
7.3.5.6.3. Market size and forecast, by Surgical approach
7.3.5.6.4. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Disease type
7.4.3. Market size and forecast, by Surgical approach
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Disease type
7.4.5.1.3. Market size and forecast, by Surgical approach
7.4.5.1.4. Market size and forecast, by End User
7.4.5.2. China
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Disease type
7.4.5.2.3. Market size and forecast, by Surgical approach
7.4.5.2.4. Market size and forecast, by End User
7.4.5.3. India
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Disease type
7.4.5.3.3. Market size and forecast, by Surgical approach
7.4.5.3.4. Market size and forecast, by End User
7.4.5.4. Australia
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Disease type
7.4.5.4.3. Market size and forecast, by Surgical approach
7.4.5.4.4. Market size and forecast, by End User
7.4.5.5. South Korea
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Disease type
7.4.5.5.3. Market size and forecast, by Surgical approach
7.4.5.5.4. Market size and forecast, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Key market trends, growth factors and opportunities
7.4.5.6.2. Market size and forecast, by Disease type
7.4.5.6.3. Market size and forecast, by Surgical approach
7.4.5.6.4. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Disease type
7.5.3. Market size and forecast, by Surgical approach
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Disease type
7.5.5.1.3. Market size and forecast, by Surgical approach
7.5.5.1.4. Market size and forecast, by End User
7.5.5.2. Saudi Arabia
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Disease type
7.5.5.2.3. Market size and forecast, by Surgical approach
7.5.5.2.4. Market size and forecast, by End User
7.5.5.3. South Africa
7.5.5.3.1. Key market trends, growth factors and opportunities
7.5.5.3.2. Market size and forecast, by Disease type
7.5.5.3.3. Market size and forecast, by Surgical approach
7.5.5.3.4. Market size and forecast, by End User
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Key market trends, growth factors and opportunities
7.5.5.4.2. Market size and forecast, by Disease type
7.5.5.4.3. Market size and forecast, by Surgical approach
7.5.5.4.4. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2021
CHAPTER 9: COMPANY PROFILES
9.1. Conkin surgical instruments ltd
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.2. KARL STORZ GmbH & Co. KG
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.3. CONMED Corporation
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.4. Richard Wolf GmbH
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.5. fortimedix surgical b.v.
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.6. Johnson & Johnson
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.7. Laborie, Inc
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.8. Cooper Companies, Inc.
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Business performance
9.8.7. Key strategic moves and developments
9.9. B. Braun Melsungen AG
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.10. Medtronic plc
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance

LIST OF TABLES
TABLE 01. GLOBAL HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 02. HYSTERECTOMY DEVICE MARKET FOR UTERINE CANCER, BY REGION, 2021-2031 ($MILLION)
TABLE 03. HYSTERECTOMY DEVICE MARKET FOR FIBROIDS, BY REGION, 2021-2031 ($MILLION)
TABLE 04. HYSTERECTOMY DEVICE MARKET FOR CHRONIC PELVIC PAIN, BY REGION, 2021-2031 ($MILLION)
TABLE 05. HYSTERECTOMY DEVICE MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 06. GLOBAL HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 07. HYSTERECTOMY DEVICE MARKET FOR VAGINAL HYSTERECTOMY, BY REGION, 2021-2031 ($MILLION)
TABLE 08. HYSTERECTOMY DEVICE MARKET FOR LAPAROSCOPIC HYSTERECTOMY, BY REGION, 2021-2031 ($MILLION)
TABLE 09. HYSTERECTOMY DEVICE MARKET FOR ROBOTIC ASSISTED LAPAROSCOPIC HYSTERECTOMY, BY REGION, 2021-2031 ($MILLION)
TABLE 10. HYSTERECTOMY DEVICE MARKET FOR ABDOMINAL HYSTERECTOMY, BY REGION, 2021-2031 ($MILLION)
TABLE 11. GLOBAL HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 12. HYSTERECTOMY DEVICE MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
TABLE 13. HYSTERECTOMY DEVICE MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2021-2031 ($MILLION)
TABLE 14. HYSTERECTOMY DEVICE MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 15. HYSTERECTOMY DEVICE MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 16. NORTH AMERICA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 17. NORTH AMERICA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 18. NORTH AMERICA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 19. NORTH AMERICA HYSTERECTOMY DEVICE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 20. U.S. HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 21. U.S. HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 22. U.S. HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 23. CANADA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 24. CANADA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 25. CANADA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 26. MEXICO HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 27. MEXICO HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 28. MEXICO HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 29. EUROPE HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 30. EUROPE HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 31. EUROPE HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 32. EUROPE HYSTERECTOMY DEVICE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 33. GERMANY HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 34. GERMANY HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 35. GERMANY HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 36. FRANCE HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 37. FRANCE HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 38. FRANCE HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 39. UK HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 40. UK HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 41. UK HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 42. ITALY HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 43. ITALY HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 44. ITALY HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 45. SPAIN HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 46. SPAIN HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 47. SPAIN HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 48. REST OF EUROPE HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 49. REST OF EUROPE HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 50. REST OF EUROPE HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 51. ASIA-PACIFIC HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 52. ASIA-PACIFIC HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 53. ASIA-PACIFIC HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 54. ASIA-PACIFIC HYSTERECTOMY DEVICE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 55. JAPAN HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 56. JAPAN HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 57. JAPAN HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 58. CHINA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 59. CHINA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 60. CHINA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 61. INDIA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 62. INDIA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 63. INDIA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 64. AUSTRALIA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 65. AUSTRALIA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 66. AUSTRALIA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 67. SOUTH KOREA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 68. SOUTH KOREA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 69. SOUTH KOREA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 73. LAMEA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 74. LAMEA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 75. LAMEA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 76. LAMEA HYSTERECTOMY DEVICE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 77. BRAZIL HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 78. BRAZIL HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 79. BRAZIL HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 80. SAUDI ARABIA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 81. SAUDI ARABIA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 82. SAUDI ARABIA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 83. SOUTH AFRICA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 84. SOUTH AFRICA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 85. SOUTH AFRICA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 86. REST OF LAMEA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 87. REST OF LAMEA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 88. REST OF LAMEA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 89. CONKIN SURGICAL INSTRUMENTS LTD: KEY EXECUTIVES
TABLE 90. CONKIN SURGICAL INSTRUMENTS LTD: COMPANY SNAPSHOT
TABLE 91. CONKIN SURGICAL INSTRUMENTS LTD: PRODUCT SEGMENTS
TABLE 92. CONKIN SURGICAL INSTRUMENTS LTD: PRODUCT PORTFOLIO
TABLE 93. KARL STORZ GMBH & CO. KG: KEY EXECUTIVES
TABLE 94. KARL STORZ GMBH & CO. KG: COMPANY SNAPSHOT
TABLE 95. KARL STORZ GMBH & CO. KG: PRODUCT SEGMENTS
TABLE 96. KARL STORZ GMBH & CO. KG: PRODUCT PORTFOLIO
TABLE 97. CONMED CORPORATION: KEY EXECUTIVES
TABLE 98. CONMED CORPORATION: COMPANY SNAPSHOT
TABLE 99. CONMED CORPORATION: PRODUCT SEGMENTS
TABLE 100. CONMED CORPORATION: PRODUCT PORTFOLIO
TABLE 101. RICHARD WOLF GMBH: KEY EXECUTIVES
TABLE 102. RICHARD WOLF GMBH: COMPANY SNAPSHOT
TABLE 103. RICHARD WOLF GMBH: PRODUCT SEGMENTS
TABLE 104. RICHARD WOLF GMBH: PRODUCT PORTFOLIO
TABLE 105. FORTIMEDIX SURGICAL B.V.: KEY EXECUTIVES
TABLE 106. FORTIMEDIX SURGICAL B.V.: COMPANY SNAPSHOT
TABLE 107. FORTIMEDIX SURGICAL B.V.: PRODUCT SEGMENTS
TABLE 108. FORTIMEDIX SURGICAL B.V.: PRODUCT PORTFOLIO
TABLE 109. JOHNSON & JOHNSON: KEY EXECUTIVES
TABLE 110. JOHNSON & JOHNSON: COMPANY SNAPSHOT
TABLE 111. JOHNSON & JOHNSON: PRODUCT SEGMENTS
TABLE 112. JOHNSON & JOHNSON: PRODUCT PORTFOLIO
TABLE 113. LABORIE, INC: KEY EXECUTIVES
TABLE 114. LABORIE, INC: COMPANY SNAPSHOT
TABLE 115. LABORIE, INC: PRODUCT SEGMENTS
TABLE 116. LABORIE, INC: PRODUCT PORTFOLIO
TABLE 117. COOPER COMPANIES, INC.: KEY EXECUTIVES
TABLE 118. COOPER COMPANIES, INC.: COMPANY SNAPSHOT
TABLE 119. COOPER COMPANIES, INC.: PRODUCT SEGMENTS
TABLE 120. COOPER COMPANIES, INC.: PRODUCT PORTFOLIO
TABLE 121. COOPER COMPANIES, INC.: KEY STRATERGIES
TABLE 122. B. BRAUN MELSUNGEN AG: KEY EXECUTIVES
TABLE 123. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
TABLE 124. B. BRAUN MELSUNGEN AG: PRODUCT SEGMENTS
TABLE 125. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
TABLE 126. MEDTRONIC PLC: KEY EXECUTIVES
TABLE 127. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 128. MEDTRONIC PLC: PRODUCT SEGMENTS
TABLE 129. MEDTRONIC PLC: PRODUCT PORTFOLIO

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 子宮摘出機器の世界市場2021-2031：機会分析・産業予測(Hysterectomy Device Market By Disease type (Uterine Cancer, Fibroids, Chronic pelvic pain, Others), By Surgical approach (Vaginal hysterectomy, Laparoscopic hysterectomy, Robotic assisted laparoscopic hysterectomy, Abdominal hysterectomy), By End User (Hospitals, Ambulatory Surgical Centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 角膜インプラントの世界市場2021-2031：機会分析・産業予測
  • 出生前・新生児遺伝学的検査の世界市場2021-2031：機会分析・産業予測

    • ◆H&Iグローバルリサーチのお客様（例）◆